For example, a study has indicated that inhibiting mTORC1 activity in endothelial cells can reduce the production of prostaglandin E2 and lead to hypertension by lowering YAP-mediated COX-2/mPGES-1 expression[31]. This evidence concerns the gene PTGS2 and hypertensive disorder.